BCM
JNJ icon

Brooktree Capital Management’s Johnson & Johnson JNJ Stock Holding History

Brooktree Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.64M Sell
14,903
-14,976
-50% -$3.49M 2.89% 10
2025
Q4 		$6.18M Sell
29,879
-349
-1% -$69K 4.11% 9
2025
Q3 		$5.6M Buy
30,228
+1,379
+5% +$236K 3.56% 10
2025
Q2 		$4.41M Buy
28,849
+2,897
+11% +$445K 2.88% 10
2025
Q1 		$4.3M Buy
25,952
+64
+0.2% +$10K 3.23% 10
2024
Q4 		$3.74M Buy
25,888
+414
+2% +$64.2K 2.78% 10
2024
Q3 		$4.13M Sell
25,474
-1,797
-7% -$286K 3.35% 10
2024
Q2 		$3.99M Sell
27,271
-1,577
-5% -$235K 3.41% 11
2024
Q1 		$4.56M Sell
28,848
-909
-3% -$145K 3.52% 11
2023
Q4 		$4.66M Sell
29,757
-833
-3% -$128K 3.77% 11
2023
Q3 		$4.76M Sell
30,590
-407
-1% -$67.2K 3.98% 10
2023
Q2 		$5.13M Sell
30,997
-2,553
-8% -$412K 3.9% 10
2023
Q1 		$5.2M Buy
33,550
+138
+0.4% +$22.3K 4.05% 11
2022
Q4 		$5.9M Sell
33,412
-572
-2% -$98.8K 4.85% 9
2022
Q3 		$5.55M Buy
33,984
+1,090
+3% +$184K 4.57% 9
2022
Q2 		$5.84M Sell
32,894
-491
-1% -$87.5K 4.39% 10
2022
Q1 		$5.92M Buy
33,385
+3,031
+10% +$516K 3.86% 10
2021
Q4 		$5.19M Sell
30,354
-472
-2% -$77.3K 3.17% 11
2021
Q3 		$4.98M Hold
30,826
– – 3.17% 11
2021
Q2 		$5.08M Buy
30,826
+409
+1% +$67.7K 3.26% 11
2021
Q1 		$5M Hold
30,417
– – 3.35% 9
2020
Q4 		$4.79M Sell
30,417
-1,855
-6% -$274K 3.52% 9
2020
Q3 		$4.8M Sell
32,272
-45
-0.1% -$6.66K 4.07% 8
2020
Q2 		$4.54M Sell
32,317
-65
-0.2% -$9.47K 4.27% 8
2020
Q1 		$4.25M Sell
32,382
-293
-0.9% -$41.6K 4.92% 6
2019
Q4 		$4.77M Buy
+32,675
New +$4.43M 4.37% 5

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brooktree Capital Management's JNJ Position: Q1 2026 in Review

Brooktree Capital Management reduced its Johnson & Johnson (JNJ) stake by 50% in Q1 2026, selling an estimated $3.49M and leaving 14,903 shares worth $3.64M. The position accounts for 2.89% of the portfolio, ranked #10.

Brooktree Capital Management first reported a position in JNJ in Q4 2019 and has held it in 26 quarters since. The position peaked at $6.18M in Q4 2025. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Brooktree Capital Management held 14,903 shares of Johnson & Johnson worth $3.64M as of Q1 2026.
  • Brooktree Capital Management sold 14,976 Johnson & Johnson shares in Q1 2026, an estimated $3.49M.
  • Johnson & Johnson made up 2.89% of Brooktree Capital Management's portfolio in Q1 2026, its #10 holding.
  • Brooktree Capital Management first reported a position in Johnson & Johnson in Q4 2019 and has held it in 26 quarters since.
  • Brooktree Capital Management's Johnson & Johnson position peaked at $6.18M in Q4 2025.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Brooktree Capital Management's 13F filing for Q1 2026, filed 6 May 2026.